Trinity Biotech Faces Rising Short Interest Amid Stock Plungeby Mark Eisenberg 15.06.2024Trinity Biotech (NASDAQ:TRIB) stock plummets 19.7%, with shares opening at $2.78. Despite a 52-week high of $5.50, the market cap ...
Dogecoin Price Prediction Amid Whale Surge: $0.03 Next?by John Darbie 15.06.2024Dogecoin tumbles 7.31% to $0.1365 amid rising bearish sentiment, plummeting 7% this week; potential drop to $0.12 or even $0.1 ...
Direxion Technology Bull 3X Shares Surge to $98, Up on High Volumeby Lilu Anderson 15.06.2024Direxion Daily Technology Bull 3X Shares (NYSEARCA:TECL) surged to $98.01; major investments from Bank of Nova Scotia, EP Wealth Advisors, ...
BlackRock CIO Bets Big on DTX Over Ethereum & Polygonby John Darbie 15.06.2024DTX Exchange's utility token, DTX, is set to outperform Ethereum and Polygon due to its unique ecosystem advantages, making it ...
Options Solutions & Major Firms Up Stakes in Micron Techby Terry Bingman 15.06.2024FMR LLC, Wellington Management, Morgan Stanley increased stakes in Micron Tech; insiders sold 372,446 shares, stock opened at $141.36, down ...
FIL Ltd Holds $178.76M in iShares U.S. Tech ETFby Lilu Anderson 15.06.2024Technology ETF performance surged in Q4 with various increases, notably a 51.4% spike. IYW shares opened at $151.08. Full report ...
Ethereum ETF Boost: Shiba Inu Soars Amid Memecoin Maniaby John Darbie 15.06.2024The Ethereum ETF’s impact on Shiba Inu (SHIB), rising institutional interest, and the surge in Solana's memecoins highlight crypto growth ...
Ethereum on Track to Shatter ATH, Analyst Predicts $8,348by John Darbie 15.06.2024Ethereum's path to an all-time high is unavoidable, with a potential breakout leading to a 75% gain. Meanwhile, Bitcoin faces ...
Madrigal Pharma Exec Sells $570K in Stock Amid Analyst Focusby Mark Eisenberg 15.06.2024Waltermire sells 2,000 shares at $285 each, netting $570K; Madrigal Pharmaceuticals sees mixed analyst reports with H.C. Wainwright lowering its ...
Avidity Biosciences CFO Sells $3.7M in Stock Amid Positive Newsby Terry Bingman 15.06.2024Avidity Biosciences sees share ownership shift as MacLean reduces holding under Rule 10b5-1 Plan; positive sector developments bolster outlook.